Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
Open accessThe DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
BACKGROUND: There are several methods of assessing nutritional status in cancer of which serum albumin is one of the most commonly used. In recent years, the role of malnutrition as a predictor of survival in cancer has received considerable attention. As a result, it is reasonable to investigate whether serum albumin has utility as a prognostic indicator of cancer survival in cancer. This review summarizes all available epidemiological literature on the association between pretreatment serum albumin levels and survival in different types of cancer. METHODS: A systematic search of the literature using the MEDLINE database (January 1995 through June 2010) to identify epidemiologic studies on the relationship between serum albumin and cancer survival. To be included in the review, a study must have: been published in English, reported on data collected in humans with any type of cancer, had serum albumin as one of the or only predicting factor, had survival as one of the outcome measures (primary or secondary) and had any of the following study designs (case-control, cohort, cross-sectional, case-series prospective, retrospective, nested case-control, ecologic, clinical trial, meta-analysis). RESULTS: Of the 29 studies reviewed on cancers of the gastrointestinal tract, all except three found higher serum albumin levels to be associated with better survival in multivariate analysis. Of the 10 studies reviewed on lung cancer, all excepting one found higher serum albumin levels to be associated with better survival. In 6 studies reviewed on female cancers and multiple cancers each, lower levels of serum albumin were associated with poor survival. Finally, in all 8 studies reviewed on patients with other cancer sites, lower levels of serum albumin were associated with poor survival. CONCLUSIONS: Pretreatment serum albumin levels provide useful prognostic significance in cancer. Accordingly, serum albumin level could be used in clinical trials to better define the baseline risk in cancer patients. A critical gap for demonstrating causality, however, is the absence of clinical trials demonstrating that raising albumin levels by means of intravenous infusion or by hyperalimentation decreases the excess risk of mortality in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“both responses to inflammation shown to be strongly prognostic across cancer types and treatment settings 27,28 .”
From A gut microbial signature for combination immune checkpoint blockade across cancer types (2024) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prognostic effect of weight loss prior tochemotherapy in cancer patients
Dewys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., et al. (1980) · The American Journal of Medicine · doi:10.1016/s0149-2918(05)80001-3 · Cited by 2,354 · cited 1×
“treatment, increased risk of chemotherapy-induced toxicity and a reduction in cancer survival [14].”
Background(2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977
Bauer, J., Capra, S., & Ferguson, M. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601412 · Cited by 1,178 · cited 4×
“Among the most commonly used tools to measure nutritional status are subjective global assessment (SGA) [16-18], bioelectrical impedance analysis (BIA) [19], and laboratory measurements of serum albumin [20], preal-bumin, and transferrin [21,22].”
MethodInfluentialGibbs, J. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.1.36 · Cited by 1,005 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [35-38], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundMcMillan, D. C., Crozier, J. E. M., Canna, K., Angerson, W. J., & McArdle, C. S. (2007) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0259-6 · Cited by 533
Impact of body mass index and albumin on morbidity and mortality after cardiac surgery
Engelman, D. T., Adams, D. H., Byrne, J. G., Aranki, S. F., Collins, J. J., Couper, G. S., Allred, E. N., Cohn, L. H., & Rizzo, R. J. (1999) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(99)70056-5 · Cited by 493 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [35-38], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundMcMillan, D. C., Watson, W. S., O'Gorman, P., Preston, T., Scott, H. R., & McArdle, C. S. (2001) · Nutrition and Cancer · doi:10.1207/s15327914nc392_8 · Cited by 461 · cited 2×
“icantly and serve as good indicators of prognosis of cancer [33,34].”
BackgroundRisk factors for morbidity and mortality after colectomy for colon cancer
Longo, W. E., Virgo, K. S., Johnson, F. E., Oprian, C. A., Vernava, A. M., Wade, T. P., Phelan, M. A., Henderson, W. G., Daley, J., & Khuri, S. F. (2000) · Diseases of the Colon & Rectum · doi:10.1007/bf02237249 · Cited by 416 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [ 35-38 ], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundDetsky, A. S., Baker, J. P., Mendelson, R. A., Wolman, S. L., Wesson, D. E., & Jeejeebhoy, K. N. (1984) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607184008002153 · Cited by 412
Nutritional Assessment of the Hospitalized Patient
Blackburn, G. L., & Thornton, P. A. (1979) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31663-7 · Cited by 372
Cited by
Items 201–300 of 1,000
Njoku, K., Barr, C. E., Ramchander, N. C., & Crosbie, E. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272232 · Cited by 50
“Inflammation and malnutrition both lead to a depletion of albumin while a low lymphocyte count may represent impaired host immune-surveillance [12, 32].”
BackgroundEsfahani, A., Ghoreishi, Z., Miran, M. A., Sanaat, Z., Ostadrahimi, A., Ziaei, J. E., Nahand, M. G., Jafarabadi, M. A., Sorusheh, Y., & Esmaili, H. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.853766 · Cited by 50
Zhang, B., Yu, W., Zhou, L., He, Z., Shen, C., He, Q., Li, J., Liu, L.-B., Wang, C., Chen, X., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144961 · Cited by 50
“Serum albumin has been used to evaluate prognosis of numerous cancers, including UTUC, and the results of those studies have been fairly consistent: lower serum albumin is an independent predictor of poorer clinical outcome [10, 27].”
ResultEffect of nutritional status on mortality in patients undergoing coronary artery bypass grafting
Keskin, M., İpek, G., Aldağ, M., Altay, S., Hayıroğlu, M. İ., Börklü, E. B., İnan, D., & Kozan, Ö. (2017) · Nutrition · doi:10.1016/j.nut.2017.10.024 · Cited by 56
Seely, D., Legacy, M., Auer, R. C., Fazekas, A., Delic, E., Anstee, C., Angka, L., Kennedy, M. A., Tai, L., Zhang, T., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100763 · Cited by 56
Zhang, X., Wang, D., Sun, T., Li, W., & Dang, C. (2022) · BMC Cancer · doi:10.1186/s12885-022-09774-z · Cited by 49
“In fact, low serum albumin is associated with poor prognosis in gastrointestinal tumors [9, 24].”
BackgroundRamadori, G. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076658 · Cited by 63
“This is even more significant when accompanied by an elevated CRP serum level [126] or by increased CRP and IL-6 serum levels [127] in almost all benign [128,129] and malignant pathological conditions that lead to hospitalization [130,131].”
BackgroundNoble, F., Hopkins, J. C. A., Curtis, N. J., Kelly, J. J., Bailey, I. S., Byrne, J. P., Bateman, A. C., Bateman, A. R., & Underwood, T. (2013) · Medical Oncology · doi:10.1007/s12032-013-0596-6 · Cited by 49
“However, serum albumin is one of the most commonly used methods to assess nutritional status, and a recent systematic review of the epidemiological literature has confirmed serum albumin as a prognostic indicator of cancer survival [65].”
Yao, Y., Zhao, M., Yuan, D., Gu, X., Liu, H., & Song, Y. (2014) · PubMed Central · doi:10.3978/j.issn.2072-1439.2014.07.13 · Cited by 55
“Previous studies successively proved that low albumin level was associated with malignant disease and was related to poor prognosis in many cancers, such as breast cancer, ovarian cancer, bladder cancer and lung cancer (7,9,18-21).”
BackgroundImpact of cachexia on outcomes in aggressive lymphomas
Karmali, R., Alrifai, T., Fughhi, I., Ng, R., Chukkapalli, V., Shah, P., Basu, S., Nathan, S., Szymanski, K., Gordon, L. I., et al. (2017) · Annals of Hematology · doi:10.1007/s00277-017-2958-1 · Cited by 50
Sun, F., Peng, H.-X., Gao, Q., Li, S., Zhang, J., Chen, Q.-G., Jiang, Y., Zhang, L., Wang, X.-Z., & Ying, H. (2018) · Cancer Management and Research · doi:10.2147/cmar.s167398 · Cited by 47
“16,17 Hence, we hypothesized that the two new biomarkers, Alb-to-Fib ratio (AFR) and Fib-to-pre-Alb ratio (FPR), might reflect the severity of systemic inflammation and predict the survival of CRC individuals.”
Sato, R., Oikawa, M., Kakita, T., Okada, T., Abe, T., Yazawa, T., Tsuchiya, H., Akazawa, N., Sato, M., Ohira, T., et al. (2020) · Surgery Today · doi:10.1007/s00595-020-02007-5 · Cited by 48
Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis
Luan, C., Wang, F., Wei, N., & Chen, B. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01535-x · Cited by 47
Xie, H., Huang, S., Yuan, G., Kuang, J., Yan, L., Wei, L., Tang, S., & Gan, J. (2020) · PeerJ · doi:10.7717/peerj.10100 · Cited by 46
Enhanced Recovery After Surgery (ERAS) in Surgical Oncology
Ripollés‐Melchor, J., Abad‐Motos, A., & Vaca, A. Z. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01282-4 · Cited by 59
Kim, Y., Lee, J., Cho, E., Lee, H. S., Shin, S., Park, E. J., Baik, S. H., Lee, K. Y., & Kang, J. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13183 · Cited by 47
“A meta-analysis of 29 studies showed that serum albumin measured before cancer treatment was a meaningful prognostic factor for better survival, supporting this hypothesis.(32) In addition, Haskins et al.”
ResultRelationship of obesity with serum concentrations of leptin, CRP and IL-6 in breast cancer survivors
Babaei, Z., Moslemi, D., Parsian, H., Khafri, S., Pouramir, M., & Mosapour, A. (2015) · Journal of the Egyptian National Cancer Institute · doi:10.1016/j.jnci.2015.09.001 · Cited by 45
The Prognostic Nutritional Index Predicts Survival and Identifies Aggressiveness of Gastric Cancer
Eo, W. K., Chang, H. J., Suh, J. H., Ahn, J. S., Shin, J., Hur, J.-Y., Kim, G. Y., Lee, S., Park, S., & Lee, S. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1082112 · Cited by 45
“However, lack of clinical trials demonstrating that preoperative correction of hypoalbuminemia or perioperative immunonutrition can improve the prognosis in gastric cancer can be the critical limitation (25, 36).”
BackgroundJoshi, S., Kumar, S., Ponnusamy, M. P., & Batra, S. K. (2016) · Oncogene · doi:10.1038/onc.2016.119 · Cited by 52
Chen, J., Song, P., Peng, Z., Liu, Z., Yang, L., Wang, L., Zhou, J., & Dong, Q. G. (2022) · Nutrition and Cancer · doi:10.1080/01635581.2022.2059091 · Cited by 50
“In addition, cancer patients often have hypoalbuminemia resulting from malnutrition and inflammation, increasing the risk of postoperative complications and worsening survival (6, 82, 83).”
BackgroundLiu, J., Chen, S., Geng, Q., Liu, X., Kong, P., Zhan, Y., & Xu, D. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s99282 · Cited by 45
Larsen, M. T., Mandrup, O. A., Schelde, K. K., Luo, Y., Sørensen, K. D., Dagnæs‐Hansen, F., Cameron, J., Stougaard, M., Steiniche, T., & Howard, K. A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.004 · Cited by 49
The nutritional assessment of head and neck cancer patients
Magnano, M., Mola, P., Machetta, G., Maffeis, P., Forestiero, I., Cavagna, R., Artino, E., & Boffano, P. (2014) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-014-3462-z · Cited by 47
“Therefore, albumin and transferrin can be viewed as indicators of inflammatory processes that will accelerate nutritional depletion [22].”
BackgroundMethodInfluentialYan, D., Shen, Z., Zhang, S., Hu, L., Sun, Q., Xu, K., Jin, Y., & Sang, W. (2021) · Journal of Cancer · doi:10.7150/jca.62340 · Cited by 46
“Low level of albumin is associated with poor prognosis in cancer patients and may serve as an independent indicator for requiring aggressive nutritional interventions [30, 31].”
BackgroundYoo, S., Chowell, D., Valero, C., Morris, L. G. T., & Chan, T. A.-T. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00267-7 · Cited by 45
Mękal, D., Sobocki, J., Badowska-Kozakiewicz, A. M., Sygit, K., Cipora, E., Bandurska, E., Czerw, A. I., & Deptała, A. (2023) · Cancers · doi:10.3390/cancers15153816 · Cited by 48
Li, Y., Jiang, W., Huang, J., Xia, Z., Huang, H., & Li, Z. (2013) · American Journal of Hematology · doi:10.1002/ajh.23422 · Cited by 45
“In addition, because albumin is an indicator of nutritional status, pretreatment hypoalbuminemia might reflect malnutrition or some unfavorable general health status in the host [30].”
BackgroundSulfur isotope analysis by MC-ICP-MS and application to small medical samples
Albalat, E., Télouk, P., Balter, V., Fujii, T., Bondanese, V. P., Plissonnier, M., Vlaeminck‐Guillem, V., Baccheta, J., Thiam, N. N., Miossec, P., et al. (2016) · Journal of Analytical Atomic Spectrometry · doi:10.1039/c5ja00489f · Cited by 53
Palliative pelvic radiotherapy for symptomatic rectal cancer – a prospective multicenter study
Cameron, M. G., Kersten, C., Vistad, I., van Helvoirt, R. P., Weyde, K., Undseth, C., Mjaaland, I., Skovlund, E., Fosså, S. D., & Guren, M. G. (2016) · Acta Oncologica · doi:10.1080/0284186x.2016.1191666 · Cited by 46
“While low baseline albumin level was an expected risk factor [21], it was surprising that younger age was also associated with study discontinuation due to deteriorating health.”
BackgroundKiyotoki, T., Nakamura, K., Haraga, J., Omichi, C., Ida, N., Saijo, M., Nishida, T., 楠本, 知., & Masuyama, H. (2017) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000001127 · Cited by 42
“Albumin levels reportedly decrease in accordance with increases in the levels of proinflammatory cytokines such as interleukin 1, interleukin 6, and tumor necrosis factor, which modulate albumin production.(35) However, the predictive value of sarcopenia and its correlation with the clinical characteristics and surviv…”
BackgroundYu, W. L., Ye, Z., Fang, X., Jiang, X., & Jiang, Y. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0563-8 · Cited by 43
Oba, T., Maeno, K., Takekoshi, D., Ono, M., Ito, T., Kanai, T., & Ito, K. (2020) · BMC Cancer · doi:10.1186/s12885-020-6647-4 · Cited by 43
Moramarco, S., Morciano, L., Morucci, L., Messinese, M., Gualtieri, P., Carestia, M., Ciccacci, F., Orlando, S., Buonomo, E., Legramante, J. M., et al. (2020) · Nutrients · doi:10.3390/nu12123656 · Cited by 59
“biomarker of many diseases, such as cancer [2], ischemia [3], and obesity [4], and is used for monitoring inflammatory activity.”
BackgroundHuman plasma lipocalins and serum albumin: Plasma alternative carriers?
di Masi, A., Trezza, V., Leboffe, L., & Ascenzi, P. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.049 · Cited by 51
the INSIGHT investigators, Vinant, P., Joffin, I., Serresse, L., Grabar, S., Jaulmes, H., Daoud, M., Abitbol, G., Fouassier, P., Triol, I., et al. (2017) · BMC Palliative Care · doi:10.1186/s12904-017-0209-9 · Cited by 53
Sun, F., Tan, Y., Gao, Q., Li, S., Zhang, J., Chen, Q., Jiang, Y., Zhang, L., Ying, H., & Wang, X. (2018) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22635 · Cited by 40
Meares, C., Badran, A., & Dewar, D. (2019) · Journal of bone oncology · doi:10.1016/j.jbo.2019.100225 · Cited by 42
“Hypoalbuminaemia has been observed to be prognostic in various cancer types [30].”
BackgroundMatloubi, Z., & Hassan, Z. M. (2020) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-020-00331-2 · Cited by 43
The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis
Zhang, H., Ren, D., Jin, X., & Wu, H. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01558-4 · Cited by 42
C-reactive protein/albumin ratio as prognostic score in oral squamous cell carcinoma
Park, H.-C., Kim, M. Y., & Kim, C. (2016) · 대한구강악안면외과학회지 · doi:10.5125/jkaoms.2016.42.5.243 · Cited by 42
“8 Lymph node metastasis No Yes Distant metastasis No Yes 66 (31-83) 21 (52.”
BackgroundChen, S., Yan, H., Du, J., Li, J., Shen, B., Ying, H., Zhang, Y., & Chen, S. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.04.012 · Cited by 42
Liu, J., Wang, F., Shao-hong, L., Huang, W., Jia, Y., & Wei, C. (2018) · Bioscience Reports · doi:10.1042/bsr20180214 · Cited by 45
Gündoğ, M., & Basaran, H. (2019) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-019-05595-2 · Cited by 41
Executive Committee of the German Medical Association on the Recommendation of the Scientific Advisory Board (2016) · Transfusion Medicine and Hemotherapy · doi:10.1159/000446043 · Cited by 42
Sarcopenia is an Independent Prognostic Factor in Patients With Pancreatic Cancer – a Meta-analysis
Thormann, M., Hinnerichs, M. S., Ordonez, F. B., Saalfeld, S., Perrakis, A., Croner, R. S., Omari, J., Pech, M., Zamsheva, M., Meyer, H., et al. (2022) · Academic Radiology · doi:10.1016/j.acra.2022.10.025 · Cited by 49
Jeng, L., Chan, W., & Teng, C. (2023) · Cancers · doi:10.3390/cancers15041005 · Cited by 48
Haas, M., Lein, A., Fuereder, T., Brkic, F. F., Schnoell, J., Liu, D. T., Kadletz‐Wanke, L., Heiduschka, G., & Jank, B. J. (2023) · Nutrients · doi:10.3390/nu15040880 · Cited by 45
“First, the GNRI includes albumin, which has been shown to be a valuable biomarker for malnutrition, general health, and chronic inflammation [29,30].”
BackgroundLi, K., Zeng, X., Zhang, Z., Wang, K., Pan, Y., Wu, Z., Chen, Y., & Zhao, Z. (2025) · Oncology Letters · doi:10.3892/ol.2025.14943 · Cited by 48
“Lymphocytes also serve a dual function in the progression of cancer (42).”
Influence of nutritional deficiency on prognosis of renal cell carcinoma ( RCC )
Ko, K., Park, Y. H., Lee, J. W., Ku, J. H., Kwak, C. H., & Kim, H. H. (2013) · British Journal of Urology · doi:10.1111/bju.12275 · Cited by 40
Li, Q., Meng, X., Liang, L., Xu, Y., Cai, G., & Cai, S. (2015) · Europe PMC (PubMed Central) · Cited by 44
Zhang, H., Zhang, B., Zhu, K., Wu, C., Gao, L., Sun, X., Liu, C., & Wang, C. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26766 · Cited by 40
“The activation of proinflammatory cytokines such as tumor necrosis factor (TNF) and interleukin‐6 can modulate albumin production and facilitate tumor progression (Barber, Ross, & Fearon, 1999; Gupta & Lis, 2010; McMillan et al., 2001; Seaton, 2001).”
BackgroundSynthesis, Detailed Characterization, and Dual Drug Delivery Application of BSA Loaded Aquasomes
Damera, D. P., Kaja, S., Janardhanam, L. S. L., Alim, S., Venuganti, V. V. K., & Nag, A. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00635 · Cited by 43
Barzi, A., Miksad, R. A., Surinach, A., Corvino, F. A., Wang, S., Torres, A. Z., Mamlouk, K. K., Pulgar, S. J., Valderrama, A., Bekaii‐Saab, T., et al. (2020) · Pancreas · doi:10.1097/mpa.0000000000001479 · Cited by 40
Prognostic Value of Pretreatment Albumin to Globulin Ratio in Lung Cancer: A Meta-Analysis
Li, J., Wang, Y., Wu, Y., Li, J., & Che, G. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1737155 · Cited by 40
Rosli, D., Shahar, S., Manaf, Z. A., Lau, H. J., Yusof, N. Y. M., Haron, M. R., & Majid, H. A. (2020) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1987 · Cited by 46
Akkaş, E. A., Erdiş, E., & Yücel, B. (2023) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-023-07954-6 · Cited by 42
“Low serum albumin level is an independent prognostic factor related to poor survival in various cancers [37, 38].”
BackgroundHe, Z., Ke, C., Al-Nahari, F., Duan, H., Guo, C., Wang, Y., Zhang, X.-H., Chen, Y.-S., Liu, Z.-G., Wang, J., et al. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2361-0 · Cited by 39
“Previous studies have demonstrated that low serum albumin is an independent predictor of outcomes across various cancers including glioblastoma [22, 23].”
BackgroundFan, L., Wang, X., Chi, C., Wang, Y., Cai, W., Shao, X., Xu, F., Pan, J., Zhu, Y., Shangguan, X., et al. (2017) · The Prostate · doi:10.1002/pros.23381 · Cited by 40
“Recently, the role of nutrition and immunological status has received considerable attention as the predictor for the survival of cancer patients.(20,28) Serum albumin level is a simple surrogatemarker for estimating protein levels, and it is commonly used as an indicator of nutritional status.”
Prognostic Factors in Patients with Symptomatic Spinal Metastases and Normal Neurological Function
Switlyk, M. D., Kongsgaard, U. E., Skjeldal, S., Hald, J. K., Hole, K. H., Knutstad, K., & Zaikova, O. (2015) · Clinical Oncology · doi:10.1016/j.clon.2015.01.002 · Cited by 38
“Serum albumin is used to assess nutritional status, severity of disease and disease progression in the oncological population [39].”
BackgroundPrognostic nutritional index as a predictor of survival in patients with recurrent cervical cancer
Ida, N., Nakamura, K., Saijo, M., 楠本, 知., & Masuyama, H. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1508 · Cited by 38
“Albumin levels decrease with increased levels of pro‑inflammatory cytokines such as IL‑1, IL‑6, and tumor necrosis factor, which modulate albumin production (21).”
Naqash, A. R., Stroud, C. R. G., Butt, M., Dy, G. K., Hegde, A. M., Muzaffar, M., Yang, L. V., Hafiz, M., Cherry, C. R., & Walker, P. R. (2017) · Acta Oncologica · doi:10.1080/0284186x.2017.1415460 · Cited by 40
“Moreover, albumin and lymphocytes that constitute the PNI, as components of the host defense are known to modulate the immune system to generate an anti-cancer response [9,16].”
BackgroundMethodRelationship of prognostic nutritional index with prognosis of gastrointestinal stromal tumors
Sun, J., Mei, Y., Zhu, Q., Shou, C., Tjhoi, W. E. H., Yang, W., Yu, H. J., Zhang, Q., Liu, X., & Yu, J. (2019) · Journal of Cancer · doi:10.7150/jca.32299 · Cited by 38
“investigated to assess the nutritional risk for gastrointestinal cancer and were found to be significant prognostic factors [13-15].”
BackgroundYonar, D., Severcan, M., Gurbanov, R., Sandal, A., Yılmaz, Ü., Emri, S., & Severcan, F. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166473 · Cited by 39
Namiuchi, S., Sugie, T., Saji, K., Takii, T., Suda, A., & Kato, A. (2014) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000184 · Cited by 38
Ma, R., Okugawa, Y., Shimura, T., Yamashita, S., Sato, Y., Yin, C., Uratani, R., Kitajima, T., Imaoka, H., Kawamura, M., et al. (2024) · Surgical Oncology · doi:10.1016/j.suronc.2024.102044 · Cited by 45
Zhou, Q., Wei, Y., Huang, F., Wei, X., Wei, Q., Hao, X., Zhang, Y., & Feng, R. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-2052-9 · Cited by 39
“Serum albumin level was increasingly accepted as an indicator of nutritional and inflammatory status [13, 14, 27].”
BackgroundA nomogram based on serum bilirubin and albumin levels predicts survival in gastric cancer patients
Sun, H., He, B., Nie, Z., Pan, Y., Kang, L., Peng, H.-X., Xu, T., Chen, X., Hu, X., Wu, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17181 · Cited by 37
“Additionally, decreased levels of albumin, a factor commonly used as an indicator of nutritional status, are associated with worse outcomes in gastric cancer patients [11].”
BackgroundLidoriki, I., Schizas, D., Baili, E., Vailas, M. G., Sotiropoulou, M. G., Papalampros, A., Misiakos, E. P., Karavokyros, I., Pikoulis, E. A., & Liakakos, T. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.08.012 · Cited by 38
Tong, Z., Liu, Y., Ma, H., Zhang, J., Lin, B., Bao, X., Xu, X., Gu, C., Zheng, Y., Liu, L., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00196 · Cited by 43
“Poor nutrition status (hypoalbuminemia) has been proven to be a negative factor of survival in multiple cancers, including hepatobiliary, lung, gastrointestinal, CNS, reproductive, and breast cancers (Onate-Ocana et al., 2007; Gupta and Lis, 2010).”
BackgroundKarlsson, M., Svedman, F. C., Tebani, A., Kotol, D., Höiom, V., Fagerberg, L., Edfors, F., Uhlén, M., Brage, S. E., & Maddalo, G. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2000 · Cited by 40
“Low levels of serum albumin, a highly abundant and stable protein in the blood, has been found to be an independent adverse prognostic factor in multiple tumor types (46).”
BackgroundJeong, J. H., Heo, M., Lee, S. J., Jeong, Y. Y., Lee, J. D., & Yoo, J. (2021) · Diagnostics · doi:10.3390/diagnostics11122344 · Cited by 40
Huang, Z., Zheng, Q., Yu, Y., Zheng, H., Wu, Y., Wang, Z., Liu, L., Zhang, M., Liu, T., Li, H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07546-0 · Cited by 44
Xie, H., Wei, L., Liu, M., Liang, Y., Yuan, G., Gao, S., Wang, Q., Lin, X. H., Tang, S., & Gan, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.976216 · Cited by 38
Serum and salivary levels of albumin as diagnostic tools for oral pre-malignancy and oral malignancy
Metgud, R., & Patel, S. (2013) · Biotechnic & Histochemistry · doi:10.3109/10520295.2013.793394 · Cited by 41
“The World Health Organization estimates that by 2020, more than 15 million people will suffer from and 10 million will die each year from oral cancer (Gupta and Christopher 2010).”
BackgroundYing, J., Zhou, D., Gu, T., Huang, J., & Liu, H. (2019) · BMC Cancer · doi:10.1186/s12885-019-5490-y · Cited by 40
Chen, K.-L., Liu, Y. H., Li, W.-Y., Chen, J., Gu, Y., Geng, Q.-R., Jiang, W.-Q., Huang, H.-Q., Lin, T.-Y., Xia, Z.-J., et al. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2361-8 · Cited by 36
“Low serum albumin levels and lymphopenia are associated with an increased inflammatory response to tumors, increased cytokine release by tumors, such as interleukin-6, and increased tumor necrosis factor levels, which may be a risk factor for a more aggressive malignancy [25–27].”
BackgroundIn-Hospital Mortality in Patients Older Than 60 Years with Very Low Albumin Levels
Hannan, J. L., Radwany, S. M., & Albanese, T. (2011) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.04.009 · Cited by 36
Nakanishi, Y., Masuda, T., Yamaguchi, K., Sakamoto, S., Horimasu, Y., Mimae, T., Nakashima, T., Miyamoto, S., Tsutani, Y., Iwamoto, H., et al. (2019) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01539-2 · Cited by 35
Lei, J., Wang, Y., Guo, X., Yan, S., Ma, D., Wang, P., Li, B., Du, W., Guo, R., & Kan, Q. (2020) · Future Oncology · doi:10.2217/fon-2019-0732 · Cited by 35
Matsuura, S., Shibazaki, K., Uchida, R., Imai, Y., Mukoyama, T., Shibata, S., & Morita, H. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13792 · Cited by 40
Tanrıverdi, Ö., Avcı, N., Oktay, E., Kalemci, S., Pilancı, K. N., Çokmert, S., Menekşe, S., Kocar, M., Şen, C. A., Akman, T., et al. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.14.5971 · Cited by 36
“…impact on certain cancer types and different cancer stages and that hypoalbuminemia is associated with poor prognosis (Gupta et al., 2009; Gupta and Lis, 2010; Ku et al., 2014; Zhang et al., 2014) In addition, the studies including patients with lung cancer have demonstrated that serum…”
BackgroundZhu, J., Wang, H., Liu, C.-C., Lu, Y., & Tang, H. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2228-y · Cited by 37
“Furthermore, since albumin is a marker of nutritional status, pretreatment hypoalbuminemia might indicate malnutrition or poor health status in the patients (Gupta and Lis 2010).”
BackgroundShouval, R., de Jong, C. N., Fein, J. A., Broers, A. E. C., Danylesko, I., Shimoni, A., Reurs, M. R., Baars, A. E., van der Schaft, N., Nagler, A., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.05.005 · Cited by 34
Targeting tryptophan availability to tumors: the answer to immune escape?
Badawy, A. A. ‐. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12168 · Cited by 36
Permuth, J. B., Daly, A. C., Jeong, D. K., Choi, J. W., Cameron, M. E., Chen, D., Teer, J. K., Barnett, T. E., Li, J., Powers, B. D., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2180 · Cited by 97
Xuan, Q., Yang, Y., Ji, H., Tang, S., Zhao, J., Shao, J., & Wang, J. (2019) · Cancer Management and Research · doi:10.2147/cmar.s195324 · Cited by 35
“ALB generation can be suppressed by inflammation and malnutrition, which are the pathogenic factors of many cancers.(17) Cytokines, such as TNF and IL-6, were produced by the inflammatory response, which can reduce the ALB synthesis by the liver cells.”
BackgroundIde, S., Okugawa, Y., Omura, Y., Yamamoto, A., Ichikawa, T., Kitajima, T., Shimura, T., Imaoka, H., Fujikawa, H., Yasuda, H., et al. (2021) · World Journal of Surgical Oncology · doi:10.1186/s12957-021-02139-z · Cited by 37
Hirahara, N., Tajima, Y., Fujii, Y., Yamamoto, T., Hyakudomi, R., Taniura, T., Kaji, S., & Kawabata, Y. (2018) · Anticancer Research · doi:10.21873/anticanres.12781 · Cited by 32
Tobing, E. R. P. L., Tansol, C., Tania, C., & Sihombing, A. T. (2024) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2024.102142 · Cited by 40
Peng, F., Chen, W., Zhou, W., Li, P., Niu, H., Chen, Y., Zhu, Y., & Long, H. (2017) · International Urology and Nephrology · doi:10.1007/s11255-017-1531-0 · Cited by 34
Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery
Światły‐Błaszkiewicz, A., Horała, A., Matysiak, J., Hajduk, J., Nowak‐Markwitz, E., & Kokot, Z. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082240 · Cited by 36
“Therefore, interleukin-6 can modulate synthesis of albumin in liver and decrease its level [45].”
BackgroundBiomarkers for Malignant Pleural Mesothelioma—A Novel View on Inflammation
Vogl, M., Rosenmayr, A., Bohanes, T., Scheed, A., Brndiar, M., Stubenberger, E., & Ghanim, B. (2021) · Cancers · doi:10.3390/cancers13040658 · Cited by 37
Chan, P., Marchand, M., Yoshida, K. J., Vadhavkar, S., Wang, N., Lin, A., Wu, B. M., Ballinger, M. D., Sternheim, N., Jin, J. Y., et al. (2021) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12686 · Cited by 37
Geriatric Nutritional Risk Index and Survival of Patients With Colorectal Cancer: A Meta-Analysis
Zhao, H., Xu, L., Tang, P., & Guo, R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.906711 · Cited by 39
He, J., Tong, L., Wu, P., Wu, Y., Shi, W., & Chen, L. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s396871 · Cited by 36
“Pretreatment serum albumin has been utilized as a predictor to evaluate disease progression, the severity of disease and prognosis.(26) It has been reported that lower blood serum albumin level is an independent affecting factor of worse survival in breast cancer regardless of stages.”
MethodYang, Z., Wang, K., Ou, Y., Hu, X., Wang, Z., Wang, D., Li, X., & Ren, S. (2023) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-023-00689-9 · Cited by 37
“Further well-designed studies should be performed to fully evaluate the prognostic performance of this novel indicator for PCa.”
Li, J., Zhang, S., Hu, X., Huang, T., & Chen, M. (2024) · Surgery Today · doi:10.1007/s00595-024-02921-y · Cited by 42
“Additionally, IL-6 can prevent hepatocytes from producing albumin [27].”
Ionescu, D. C., Tibrea, C., & Puia, I. C. (2013) · PubMed · Cited by 33
Du, X.-J., Tang, L., Chen, L., Mao, Y., Guo, R., Liu, X., Sun, Y. H., Zeng, M., Kang, T., Shao, J., et al. (2015) · Scientific Reports · doi:10.1038/srep16664 · Cited by 33
Otowa, Y., Nakamura, T., Yamamoto, M., Kanaji, S., Matsuda, Y., Matsuda, T., Oshikiri, T., Sumi, Y., Suzuki, S., & Kakeji, Y. (2017) · Diseases of the Esophagus · doi:10.1093/dote/dox107 · Cited by 33
Metadata
- Authors
- Gupta, D., & Lis, C. G.
- Affiliations
- Cancer Treatment Centers of America (US)
- Corresponding author
- Lis, Christopher G
- ORCID
- Gupta, Digant
- Venue
- Nutrition Journal
- Published
- 2010-12
- Volume
- 9
- Issue
- 1
- Pages
- 69-69
- ISSN
- 1475-2891 (ISSN-L)
- PMC
- PMC3019132
- OpenAlex
- W2167127503
- Cited by
- 1,485
- References
- 98
- Citations by year
- 2026: 122 · 2025: 147 · 2024: 138 · 2023: 152 · 2022: 161 · 2021: 178 · 2020: 140 · 2019: 86 · 2018: 83 · 2017: 72 · 2016: 64 · 2015: 56 · 2014: 34 · 2013: 24 · 2012: 11
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrition Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Keywords
- serum albumin, cancer survival, prognostic factors, malnutrition, nutritional status, gastrointestinal cancer, lung cancer, women's cancer, multiple primary neoplasms, mortality risk
- MeSH terms
- Female, Humans, Male, Neoplasms, Prognosis, Serum Albumin, Nutrition Assessment, Malnutrition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.